Yu Pan et al. identified the subsets of tumor infiltrating immune cells after anti-CD47 treatment by scRNA-seq and revealed that the numbers of CD4 + T cells and CD8 + T cells were significantly increased, whereas that of Treg cells were decreased, all of which enhanced the sensitivity of the tumors to immunotherapy. The gene discussed is CD47; the disease is neoplasm.